Biological
Fluenz Tetra (The two groups are defined by immunisation history, all receive the same intervention in the study)
Fluenz Tetra (The two groups are defined by immunisation history, all receive the same intervention in the study) is a biological therapy with 1 clinical trials. Historical success rate of 100.0%.
Total Trials
1
Max Phase
—
Type
BIOLOGICAL
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_4
1
100%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution1 total trials
Phase 4Post-market surveillance
1(100.0%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
1
all time
Status Distribution
Completed(1)
Detailed Status
Completed1
Development Timeline
Analytics
Development Status
Total Trials
1
Active
0
Success Rate
100.0%
Most Advanced
Phase 4
Trials by Phase
Phase 41 (100.0%)
Trials by Status
completed1100%
Recent Activity
Clinical Trials (1)
Drug Details
- Intervention Type
- BIOLOGICAL
- Total Trials
- 1